128 related articles for article (PubMed ID: 2907624)
1. Comparison of the antinociceptive effects of new [D-Arg2]-dermorphin tetrapeptide analogs and morphine in mice.
Chaki K; Sakurada S; Sakurada T; Sato T; Kawamura S; Kisara K; Watanabe H; Suzuki K
Pharmacol Biochem Behav; 1988 Oct; 31(2):439-44. PubMed ID: 2907624
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive cross-tolerance between [D-Arg2]-dermorphin tetrapeptide analogs and morphine.
Chaki K; Sakurada S; Sakurada T; Nakata N; Kisara K; Watanabe H; Suzuki K
Peptides; 1990; 11(1):139-44. PubMed ID: 1971439
[TBL] [Abstract][Full Text] [Related]
3. Antinociception and physical dependence produced by [D-Arg2] dermorphin tetrapeptide analogues and morphine in rats.
Chaki K; Kawamura S; Kisara K; Sakurada S; Sakurada T; Sasaki Y; Sato T; Susuki K
Br J Pharmacol; 1988 Sep; 95(1):15-22. PubMed ID: 2905901
[TBL] [Abstract][Full Text] [Related]
4. The analgesic activity of D-Arg2-dermorphin and its N-terminal tetrapeptide analogs after subcutaneous administration in mice.
Sasaki Y; Matsui M; Fujita H; Hosono M; Taguchi M; Suzuki K; Sakurada S; Sato T; Sakurada T; Kisara K
Neuropeptides; 1985 Feb; 5(4-6):391-4. PubMed ID: 2860597
[TBL] [Abstract][Full Text] [Related]
5. Comparison of opioid activity between a N-terminal tetrapeptide analogue of dermorphin, H-Tyr-D-Arg-Phe-beta-Ala-OH and morphine.
Sato T; Takahashi N; Tan-No K; Kisara K; Sakurada T; Sakurada S
Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):581-6. PubMed ID: 9819802
[TBL] [Abstract][Full Text] [Related]
6. A new class opioid peptide, [D-Arg2, beta-Ala4]-dermorphin tetrapeptide; physical dependence liability in mice.
Chaki K; Sakurada S; Sakurada T; Sato T; Kawamura S; Kisara K; Sasaki Y; Suzuki K
Neuropeptides; 1989; 13(2):83-8. PubMed ID: 2567974
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of an orally available and long-acting analgesic peptide, N(alpha)-amidino-Tyr-D-Arg-Phe-MebetaAla-OH (ADAMB).
Ogawa T; Miyamae T; Murayama K; Okuyama K; Okayama T; Hagiwara M; Sakurada S; Morikawa T
J Med Chem; 2002 Nov; 45(23):5081-9. PubMed ID: 12408719
[TBL] [Abstract][Full Text] [Related]
8. Dermorphin tetrapeptide analogs as potent and long-lasting analgesics with pharmacological profiles distinct from morphine.
Mizoguchi H; Bagetta G; Sakurada T; Sakurada S
Peptides; 2011 Feb; 32(2):421-7. PubMed ID: 21126548
[TBL] [Abstract][Full Text] [Related]
9. Dermorphin analogues containing D-kyotorphin: structure-antinociceptive relationships in mice.
Kisara K; Sakurada S; Sakurada T; Sasaki Y; Sato T; Suzuki K; Watanabe H
Br J Pharmacol; 1986 Jan; 87(1):183-9. PubMed ID: 2869809
[TBL] [Abstract][Full Text] [Related]
10. Physical dependence of a dermorphin tetrapeptide analog, [D-Arg2, Sar4]-dermorphin (1-4) in the rat.
Nakata N; Sakurada S; Sakurada T; Kisara K; Sasaki Y; Suzuki K
Pharmacol Biochem Behav; 1986 Jan; 24(1):27-31. PubMed ID: 3945663
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues.
Marastoni M; Salvadori S; Balboni G; Borea PA; Marzola G; Tomatis R
J Med Chem; 1987 Sep; 30(9):1538-42. PubMed ID: 2887656
[TBL] [Abstract][Full Text] [Related]
12. N-terminal tetrapeptide of dermorphin and D-Arg-substituted tetrapeptides: inactivation process of the antinociceptive activity by peptidase.
Chaki K; Sakurada S; Sakurada T; Kisara K; Suzuki K
Life Sci; 1990; 46(23):1671-8. PubMed ID: 1972532
[TBL] [Abstract][Full Text] [Related]
13. Opioid activities of D-Arg2-substituted tetrapeptides.
Sato T; Sakurada S; Sakurada T; Furuta S; Chaki K; Kisara K; Sasaki Y; Suzuki K
J Pharmacol Exp Ther; 1987 Aug; 242(2):654-9. PubMed ID: 3612556
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the antinociceptive effect between D-Arg containing dipeptides and tetrapeptides in mice.
Sato T; Sakurada S; Sakurada T; Furuta S; Nakata N; Kisara K; Sasaki Y; Suzuki K
Neuropeptides; 1984 Jun; 4(4):269-79. PubMed ID: 6548000
[TBL] [Abstract][Full Text] [Related]
15. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs.
Gouardères C; Sutak M; Zajac JM; Jhamandas K
Eur J Pharmacol; 2000 Oct; 406(3):391-401. PubMed ID: 11040346
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1] DALDA.
Shimoyama M; Shimoyama N; Zhao GM; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2001 Apr; 297(1):364-71. PubMed ID: 11259564
[TBL] [Abstract][Full Text] [Related]
17. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
[TBL] [Abstract][Full Text] [Related]
18. D-Arg2-dermorphin tetrapeptide analogs: a potent and long-lasting analgesic activity after subcutaneous administration.
Sasaki Y; Matsui M; Taguchi M; Suzuki K; Sakurada S; Sato T; Sakurada T; Kisara K
Biochem Biophys Res Commun; 1984 Apr; 120(1):214-8. PubMed ID: 6712689
[TBL] [Abstract][Full Text] [Related]
19. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
20. Tolerance and dependence following chronic intracerebroventricular infusions of Tyr-D-Arg2-Phe-Sar4 (TAPS).
Vonhof S; Gudka BD; Sirén AL
Eur J Pharmacol; 2003 Jan; 459(1):41-8. PubMed ID: 12505532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
